Angela Shen

1 month ago | chinatalk.media | Angela Shen

Created by the United States Congress in 2022, the National Security Commission on Emerging Biotechnology (NSCEB) is an independent, bipartisan body tasked with assessing biotech’s national security implications. Modeled after the earlier AI Commission, the NSCEB recently released its report of recommendations to ensure the US's future leadership in biotechnology. Their report signals something important: biotech is moving from policy background noise to strategic priority.

1 month ago | chinatalk.media | Angela Shen |Jordan Schneider

Of all the policies Trump has rolled out, the two I’m most worried will have irreversible consequences for long term national power are undermining our alliance structure and the attractiveness of the country for high end international talent. Angela Shen (ChinaTalk’s robotics and biotech analyst) and I published a piece earlier this week in The Washington Post, arguing how America’s student visa system is critical for future science and tech success.

1 month ago | open.substack.com | Angela Shen

Of all the policies Trump has rolled out, the two I’m most worried will have irreversible consequences for long term national power are undermining our alliance structure and the attractiveness of the country for high end international talent. Angela Shen (ChinaTalk’s robotics and biotech analyst) and I published a piece earlier this week in The Washington Post, arguing how America’s student visa system is critical for future science and tech success.

2 months ago | chinatalk.media | Angela Shen

This continues a series examining China’s role in the global biotech and pharmaceutical industry, and focuses on China’s drug markets. Our first piece explored the role of AI in China’s biotech ecosystem. Future articles will cover the Chinese biopharmaceutical research, innovation, and supply chains. If you have tips on any of these topics, please reach out. As China prospers, so do its citizens’ expectations for high-quality healthcare.

2 months ago | chinatalk.media | Angela Shen

Founded in 2023, Moonshot AI is one of China’s four new “AI tigers” that’s attracted massive valuations and big-name investors including Alibaba and Tencent. The firm is known for its chatbot, Kimi, whose most recent release highlights improved math, coding, and multimodal reasoning capabilities. The following piece is a translation of an interview with one of Moonshot’s founders, Yang Zhiling.